FOLLOW THE DATA · LIMITED PILOT
Neil Goldenberg
Industry payments, explained.
See who reported payments, what they were for, and when they happened. Every amount leads back to its source.
NPI 1801971551 · Check identity ↗
01 / EXPLORE
The picture at a glance
All companies · All payment types · Full year 2024
A disclosure is not a measure of care quality or evidence of wrongdoing.
Who reported the payments?
Share of selected valueSelect a company bar to explore its records.
What were they for?
Reported payment typeSelect a type to filter the view.
When were payments reported?
Monthly value · USD · baseline $0Select a month to narrow the records. The chart keeps the full year for your company and payment-type filters.
Chart maximum: $3,375.00
Based on the CMS source-file date.
$7,593.75 across 5 source records, covering 5 reported payments.
02 / VERIFY
Behind every number, a record
Open a row for its details and the original CMS source. All amounts are record totals.
No records match this combination. Try another month or reset the filters.
2024-06-20Source-file dateJanssen Research & Development, LLCConsulting Fee$2,362.50
- Record ID
- 1077589485
- Form of payment
- Cash or cash equivalent
- Payments grouped
- 1
- Third-party indicator
- Entity
- Named third party
- ANTITHROMBOTIC CONSULTING LLC
- Disputed in this publication
- No
2024-04-18Source-file dateJanssen Research & Development, LLCConsulting Fee$506.25
- Record ID
- 1077589487
- Form of payment
- Cash or cash equivalent
- Payments grouped
- 1
- Third-party indicator
- Entity
- Named third party
- ANTITHROMBOTIC CONSULTING LLC
- Disputed in this publication
- No
2024-02-26Source-file dateJanssen Research & Development, LLCConsulting Fee$1,350.00
- Record ID
- 1077589493
- Form of payment
- Cash or cash equivalent
- Payments grouped
- 1
- Third-party indicator
- Entity
- Named third party
- ANTITHROMBOTIC CONSULTING LLC
- Disputed in this publication
- No
2024-01-12Source-file dateJanssen Research & Development, LLCConsulting Fee$1,350.00
- Record ID
- 1077589491
- Form of payment
- Cash or cash equivalent
- Payments grouped
- 1
- Third-party indicator
- Entity
- Named third party
- ANTITHROMBOTIC CONSULTING LLC
- Disputed in this publication
- No
2024-01-12Source-file dateJanssen Research & Development, LLCConsulting Fee$2,025.00
- Record ID
- 1077589489
- Form of payment
- Cash or cash equivalent
- Payments grouped
- 1
- Third-party indicator
- Entity
- Named third party
- ANTITHROMBOTIC CONSULTING LLC
- Disputed in this publication
- No
03 / USE WHAT YOU LEARNED
A better starting point
for a conversation.
A record can help you ask a specific question. It cannot tell you why a treatment was chosen.
Read the conversation checklist ↗What did the payment relate to?
“I found a reported payment from this company. What work or activity did it cover?”
Who received the value?
“Was the recipient you, your practice or another organization? Was this cash or an in-kind item?”
Could this relate to my treatment?
“Do you have a relationship with the manufacturer of this treatment, and what alternatives should we discuss?”
About this data, coverage and limitations CMS · 2026-06-30
General payments only, January–December 2024. CMS publication 2026-06-30; retrieved 2026-09-10. Research and ownership are outside this view. The provider profile has a different, multi-year scope. Identity matched by NPI and name.
Dates reproduce the CMS date_of_payment field. Transfers may be in kind or involve third parties; totals are not necessarily personal income. This limited pilot covers three providers and does not compare clinical outcomes.